STOCK TITAN
  1. Home
  2. Sec-filings
  3. LDI
  4. [8-K] loanDepot, Inc. Reports Material Event

loanDepot (NYSE: LDI) faces NYSE price warning, weighs reverse split

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

loanDepot, Inc. (LDI) disclosed that it received a notice from the New York Stock Exchange on August 21, 2026 stating that the company is not in compliance with the NYSE continued listing standard in Section 802.01C, because the average closing price of its Class A common stock was below $1.00 per share over a consecutive 30 trading-day period. Trading in the shares continues and the notice has no immediate impact on NYSE listing status, business operations, or SEC reporting.

Under NYSE rules, loanDepot has six months from receipt of the notice to regain compliance, which it can do if the stock closes at or above $1.00 and has a 30-trading-day average of at least $1.00 on the last trading day of any calendar month in that period. If it does not regain compliance, the NYSE will begin suspension and delisting procedures. The company stated it intends to cure the deficiency and is considering alternatives, including a potential reverse stock split subject to stockholder approval by its next annual meeting anticipated for early June 2027. Management also highlighted recent operational progress, including last-quarter growth of 25% in unit volume, 18% in revenue, and 33% in purchase market share.

Positive

  • Management reports last-quarter growth of 25% in unit volume, 18% in revenue, and 33% in purchase market share, indicating recent operating momentum.
  • loanDepot explicitly states its intent to cure the NYSE price deficiency and is considering alternatives including a potential reverse stock split to help restore compliance.

Negative

  • loanDepot has fallen below the NYSE’s minimum $1.00 average closing share price requirement over 30 trading days, triggering a non-compliance notice.
  • If loanDepot does not regain compliance within the six‑month cure period, the NYSE will initiate procedures to suspend and delist its Class A common stock.

Insights

Analyzing...

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Minimum NYSE share price $1.00 per share Average closing price requirement under NYSE Section 802.01C
Non-compliance measurement period 30 trading-day period Period over which the average closing price was below $1.00
Cure period Six months Time after August 21, 2026 notice to regain NYSE compliance
Unit volume growth 25% Increase in unit volume in the last quarter cited by management
Revenue growth 18% Increase in revenue in the last quarter cited by management
Purchase market share growth 33% Increase in purchase market share in the last quarter cited by management
Next annual meeting timing Early June 2027 Deadline by which a reverse stock split could be approved if pursued
continued listing standard regulatory
"not in compliance with the continued listing standard set forth in Section 802.01C"
Continued listing standards are the ongoing rules a stock exchange or trading venue requires a company to meet to keep its shares listed, such as minimum share price, market value, shareholder equity, and timely financial reporting. For investors, these standards matter because failure to meet them can trigger warnings or removal from the exchange, which can reduce a stock’s visibility, trading liquidity, and value—similar to how failing building inspections can limit a business’s ability to operate publicly.
Section 802.01C regulatory
"standard set forth in Section 802.01C of the NYSE's Listed Company Manual"
reverse stock split financial
"consider available alternatives to cure the stock price non-compliance, including, if necessary, a reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
warehouse lines of credit financial
"our ability to maintain warehouse lines of credit and other sources of capital"
A warehouse line of credit is a short-term revolving loan that a lender or dealer uses to temporarily fund assets—such as mortgages, loans, or inventory—until those assets are sold, packaged, or otherwise converted to long-term funding. Think of it as a bridge loan or an overdraft that helps keep business flowing; investors watch these lines because their size, cost, and availability signal whether a company can maintain growth, manage cash needs, and withstand market disruptions.
home equity lending financial
"We executed a successful and strategic expansion into home equity lending, at scale"
forward-looking statements regulatory
"Forward-Looking Statements This press release contains forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

Why did loanDepot (LDI) receive a non-compliance notice from the NYSE?
loanDepot received a NYSE notice because the average closing price of its Class A common stock was below $1.00 per share over a consecutive 30 trading‑day period, violating the NYSE continued listing standard in Section 802.01C.

How long does loanDepot (LDI) have to regain NYSE listing compliance?
loanDepot has a six‑month period from receipt of the NYSE notice to regain compliance. It can do so if, on the last trading day of any calendar month in that period, the stock’s closing price and 30‑day average closing price are each at least $1.00.

What happens if loanDepot (LDI) cannot meet the $1.00 share price requirement?
If loanDepot does not regain compliance with the NYSE’s $1.00 minimum share price rule within the six‑month cure period, the NYSE will initiate procedures to suspend and delist the company’s Class A common stock.

Is loanDepot (LDI) planning actions to address the NYSE price deficiency?
Yes. loanDepot intends to notify the NYSE of its intent to regain compliance and will consider alternatives to cure the deficiency, including, if necessary, a reverse stock split subject to stockholder approval by its next annual meeting anticipated for early June 2027.

Does the NYSE non-compliance notice affect loanDepot’s current trading or operations?
The notice has no immediate impact on the ability of loanDepot’s Class A common stock to trade on the NYSE or on its ongoing business operations or SEC reporting obligations during the cure period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
FALSE000183163100018316312026-08-212026-08-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 8-K
_____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (or date of earliest event reported): August 21, 2026
_____________________
loanDepot, Inc.
(Exact Name of Registrant as Specified in its Charter)
_____________________
Delaware001-4000385-3948939
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification Number)
6561 Irvine Center Drive
Irvine, California 92618
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (888) 337-6888
_____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Class A Common Stock, $0.001 Par ValueLDINew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o


Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On August 21, 2026, loanDepot, Inc. (the "Company") received a written notice (the "Notice") from the New York Stock Exchange (the "NYSE") that it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE's Listed Company Manual ("Section 802.01C"), because the average closing price of the Company's Class A Common Stock (the "Common Stock"), was less than $1.00 per share over a consecutive 30 trading-day period. The Notice has no immediate impact on the listing of the Company's Common Stock on the NYSE, subject to the Company’s compliance with the NYSE’s other continued listing requirements. The Notice does not affect the Company’s business operations or its reporting obligations with the Securities and Exchange Commission.

Pursuant to Section 802.01C, the Company has a period of six months following the receipt of the Notice to regain compliance with the minimum share price requirement. The Company may regain compliance at any time during the six-month cure period if, on the last trading day of any calendar month during the six-month cure period, the Common Stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. If the Company is unable to regain compliance with the $1.00 share price rule within this period, the NYSE will initiate procedures to suspend and delist the Common Stock. However, if the Company determines that it will cure the price condition by taking an action that will require shareholder approval, the Company must so inform the NYSE and must obtain shareholder approval no later than its next annual meeting of stockholders, and must implement the action promptly thereafter.

Section 802.01C requires the Company to notify the NYSE, within 10 business days of receipt of the Notice, of its intent to cure this deficiency. The Company intends to notify the NYSE of its intent to regain compliance with the requirements of Section 802.01C within such time period.

Item 7.01 Regulation FD Disclosure

On August 21, 2026, the Company issued a press release (the “NYSE Compliance Press Release”) related to the foregoing. A copy of the NYSE Compliance Press Release is attached as Exhibit 99.1 to this Current Report and is incorporated by reference to this Item 7.01.

The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is not to be incorporated by reference into any filing by Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language contained in such filing, unless otherwise expressly stated in such filing.

Forward-Looking Statements

This Current Report on Form 8-K may contain forward-looking statements that include, but are not limited to, statements relating to the Company’s ability to maintain the listing of its Common Stock on the NYSE, its intentions regarding regaining compliance with the minimum price condition of NYSE and the Company’s intended methods to cure such related deficiency as well as the Company’s anticipated business and financial performance. These forward-looking statements are based on current available operating, financial, economic and other information, and are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict, including but not limited to, the following: our ability to regain compliance with the minimum price condition of NYSE and cure such related deficiency; our ability to maintain listing on the NYSE; our ability to achieve the expected benefits of our strategic plans and priorities and the success of other business initiatives; our ability to achieve profitability; our ability to maintain an operating platform and management system sufficient to conduct our business; our ability to maintain warehouse lines of credit and other sources of capital and liquidity; adverse changes in macroeconomic and U.S. residential real estate and mortgage market conditions, including changes in interest rates, changes in global trade policy and tariffs, and geopolitical tensions and conflicts; our ability to address, repay and/or refinance our senior notes; and other risks detailed in the "Risk Factors" section of loanDepot, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2025, as well as any subsequent filings with the Securities and Exchange Commission. Therefore, current plans, anticipated actions, and financial results, may differ materially from what is expressed or forecasted in any forward-looking statement. loanDepot does not undertake any obligation to publicly update or revise any forward-looking statement to reflect future events or circumstances, except as required by applicable law.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.Description
99.1
August 21, 2026, Press Release
104Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
loanDepot, Inc.
By:/s/ David Hayes
Name: David Hayes
Title: Chief Financial Officer

Date: August 21, 2026



loanDepot, Inc. Addresses Notice of NYSE Trading Price Non-Compliance
•No immediate impact on listing of loanDepot’s Class A common stock or business operations
•Company intends to cure the deficiency and return to compliance with the NYSE listing standard
IRVINE, Calif.--(BUSINESS WIRE)-- loanDepot, Inc. (NYSE: LDI) (together with its subsidiaries, “loanDepot”) today announced that on August 21, it received a deficiency letter from the New York Stock Exchange (the “NYSE”) notifying loanDepot that it is not in compliance with applicable price criteria in the NYSE’s continued listing standards.
“As we continue to execute our transformation agenda to position loanDepot for profitable market share growth, we are making significant progress. In the last quarter, unit volume grew by 25%, revenue grew by 18%, and purchase market share grew by 33%. We executed a successful and strategic expansion into home equity lending, at scale, and re-entered the wholesale market,” said loanDepot Founder and Chief Executive Officer Anthony Hsieh. “We are making more loans, making them faster, and producing them at a lower cost. By continuously leveraging our unique assets, including one of the most differentiated customer acquisition and retention business models in the marketplace today, and by prudently and actively managing our capital and debt obligations, we believe we can create sustainable stockholder value. As we do that, we expect our stock price to reflect our success.”
This notice has no immediate impact on the ability of loanDepot’s Class A common stock to continue to trade on the NYSE during the cure period. Furthermore, there is no immediate impact on the ongoing business operations of loanDepot or its reporting requirements with the U.S. Securities and Exchange Commission.
The notice was received because as of August 20, 2026, the average closing price of loanDepot’s Class A Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period (the “Notice”).
loanDepot will respond to the NYSE within ten business days of receipt of the notice of its intent to cure the deficiency. Pursuant to the applicable NYSE rules, loanDepot has a six-month period following receipt of the Notice to bring its share price and average share price back above $1.00. LoanDepot will consider available alternatives to cure the stock price non-compliance, including, if necessary, a reverse stock split that would be subject to stockholder approval no later than at loanDepot’s next annual meeting of stockholders anticipated for early June 2027.




Forward Looking Statements
This press release contains forward-looking statements that can be identified by the fact that they do not relate strictly to historical or current facts and may contain the words “believe,” “aim,” “anticipate,” “expect,” “goal,” “intend,” “plan,” “predict,” “estimate,” “project,” “will be,” “will continue,” “will likely result,” or other similar words and phrases or future or conditional verbs such as “will,” “may,” “might,” “should,” “would,” or “could” and the negatives of those terms. Examples of forward-looking statements include, but are not limited to, statements relating to the Company’s ability to maintain the listing of its Common Stock on the NYSE, its intentions regarding regaining compliance with the minimum price condition of NYSE, the Company’s intended methods to cure such related deficiency, its ability to create stockholder value, and stock price expectations, as well as the Company’s anticipated business and financial performance, unique assets, capital management strategies, and profitable market share growth.
These forward-looking statements are based on current available operating, financial, economic and other information, and are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict, including but not limited to, the following: our ability to regain compliance with the minimum price condition of NYSE and cure such related deficiency; our ability to maintain listing on the NYSE; our ability to achieve the expected benefits of our strategic plans and priorities and the success of other business initiatives; our ability to effectively manage our capital and debt obligations, including by executing bond repurchases; our ability to achieve profitability; our loan production volume; our ability to maintain an operating platform and management system sufficient to conduct our business; our ability to maintain warehouse lines of credit and other sources of capital and liquidity; our ability to effectively utilize artificial intelligence and emerging technologies; adverse changes in macroeconomic and U.S residential real estate and mortgage market conditions, including changes in interest rates, changes in global trade policy and tariffs, geopolitical tensions and conflicts; our ability to address, repay and/or refinance our senior notes; and other risks detailed in the "Risk Factors" section of loanDepot, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2025, as well as any subsequent filings with the Securities and Exchange Commission. Therefore, current plans, anticipated actions, and financial results, as well as the anticipated development of the industry, may differ materially from what is expressed or forecasted in any forward-looking statement. loanDepot does not undertake any obligation to publicly update or revise any forward-looking statement to reflect future events or circumstances, except as required by applicable law.
About loanDepot
Since its launch in 2010, loanDepot (NYSE: LDI) has revolutionized the mortgage industry with digital innovations that make transacting easier, faster and less stressful for customers and originators alike. The company, which is licensed in all 50 states, helps its customers achieve the American dream of homeownership through a broad suite of lending and real estate services that


simplify one of life’s most complex transactions. loanDepot is also committed to serving the communities in which its team lives and works through a variety of local and national philanthropic efforts.
LDI-IR
Investor Contact:
Gerhard Erdelji
Senior Vice President, Investor Relations
loanDepot
(949) 822-4074 | gerdelji@loandepot.com

Media Contact:
Rebecca Anderson
Senior Vice President, Strategic Communications and Public Relations
loanDepot
(949) 822-4024 | rebeccaanderson@loandepot.com


Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

5 documents

Press Releases

Other Documents